184 related articles for article (PubMed ID: 11687699)
1. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model.
Bremer C; Bredow S; Mahmood U; Weissleder R; Tung CH
Radiology; 2001 Nov; 221(2):523-9. PubMed ID: 11687699
[TBL] [Abstract][Full Text] [Related]
2. Radioactive smart probe for potential corrected matrix metalloproteinase imaging.
Huang CW; Li Z; Conti PS
Bioconjug Chem; 2012 Nov; 23(11):2159-67. PubMed ID: 23025637
[TBL] [Abstract][Full Text] [Related]
3. Performance of a new fluorescence-labeled MMP inhibitor to image tumor MMP activity in vivo in comparison to an MMP-activatable probe.
Waschkau B; Faust A; Schäfers M; Bremer C
Contrast Media Mol Imaging; 2013; 8(1):1-11. PubMed ID: 23109387
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
5. Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice.
Funovics MA; Weissleder R; Mahmood U
Radiology; 2004 Jun; 231(3):659-66. PubMed ID: 15163807
[TBL] [Abstract][Full Text] [Related]
6. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
[TBL] [Abstract][Full Text] [Related]
7. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells.
Zhao T; Harada H; Teramura Y; Tanaka S; Itasaka S; Morinibu A; Shinomiya K; Zhu Y; Hanaoka H; Iwata H; Saji H; Hiraoka M
J Control Release; 2010 May; 144(1):109-14. PubMed ID: 20096316
[TBL] [Abstract][Full Text] [Related]
8. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):675-82. PubMed ID: 11212845
[TBL] [Abstract][Full Text] [Related]
9. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
10. Development of membrane type-1 matrix metalloproteinase-specific activatable fluorescent probe for malignant tumor detection.
Shimizu Y; Temma T; Sano K; Ono M; Saji H
Cancer Sci; 2011 Oct; 102(10):1897-903. PubMed ID: 21718387
[TBL] [Abstract][Full Text] [Related]
11. Development of MRI/NIRF 'activatable' multimodal imaging probe based on iron oxide nanoparticles.
Cha EJ; Jang ES; Sun IC; Lee IJ; Ko JH; Kim YI; Kwon IC; Kim K; Ahn CH
J Control Release; 2011 Oct; 155(2):152-8. PubMed ID: 21801769
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.
Williams RN; Parsons SL; Morris TM; Rowlands BJ; Watson SA
Eur J Surg Oncol; 2005 Nov; 31(9):1042-50. PubMed ID: 15993560
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR
Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403
[TBL] [Abstract][Full Text] [Related]
14. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer.
Zervos EE; Shafii AE; Rosemurgy AS
J Surg Res; 1999 Jan; 81(1):65-8. PubMed ID: 9889060
[TBL] [Abstract][Full Text] [Related]
16. In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia.
Klohs J; Baeva N; Steinbrink J; Bourayou R; Boettcher C; Royl G; Megow D; Dirnagl U; Priller J; Wunder A
J Cereb Blood Flow Metab; 2009 Jul; 29(7):1284-92. PubMed ID: 19417756
[TBL] [Abstract][Full Text] [Related]
17. Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice.
Alencar H; Funovics MA; Figueiredo J; Sawaya H; Weissleder R; Mahmood U
Radiology; 2007 Jul; 244(1):232-8. PubMed ID: 17507718
[TBL] [Abstract][Full Text] [Related]
18. Early diagnosis of arthritis in mice with collagen-induced arthritis, using a fluorogenic matrix metalloproteinase 3-specific polymeric probe.
Ryu JH; Lee A; Chu JU; Koo H; Ko CY; Kim HS; Yoon SY; Kim BS; Choi K; Kwon IC; Kim K; Youn I
Arthritis Rheum; 2011 Dec; 63(12):3824-32. PubMed ID: 22127700
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared optical imaging of protease activity for tumor detection.
Mahmood U; Tung CH; Bogdanov A; Weissleder R
Radiology; 1999 Dec; 213(3):866-70. PubMed ID: 10580968
[TBL] [Abstract][Full Text] [Related]
20. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
Deguchi JO; Aikawa M; Tung CH; Aikawa E; Kim DE; Ntziachristos V; Weissleder R; Libby P
Circulation; 2006 Jul; 114(1):55-62. PubMed ID: 16801460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
